Clinical Law Insight: Autumn 2022
We cover the latest on the Covid-19 Inquiry, NHS Resolution's second Early Notifications report, the roll-out of the new Patient Safety Incident Response Framework and the implications of virtual wards.
Covid-19 Public Inquiry: What you can expect from Module 3
The Covid-19 Inquiry has opened its third investigation, Module 3, which is primarily focussed on the impact of the Covid-19 pandemic on healthcare in England, Wales, Scotland and Northern Ireland.
Covid-19 Public Inquiry: What you can expect from Module 2
The Covid-19 Inquiry has opened its second investigation, Module 2, which is primarily focussed on the decisions made by the UK and devolved governments. Learn about the scope, timeframe and how we can help in our insight.
Clinical Law Insight: Summer 2022
We cover the latest on the Covid-19 Inquiry, recommendations from the Ockenden report and NHS Resolution's thematic reviews of clinical negligence claims in emergency medicine, diabetes and lower limb complications, plus an analysis of anaesthesia claims.
Covid-19 Public Inquiry formally established and Terms of Reference finalised
On 28 June, the Prime Minister set the Terms of Reference of the UK Covid-19 Inquiry, which means that the Inquiry has been formally established under the Inquiries Act 2005. Find out the key changes, topics and next step for the Inquiry in our insight.
Clinical Law Insight: Spring 2022
Read the latest on the COVID-19 Inquiry and themes for Covid-related inquests and claims. Also: the government’s response to the Paterson Inquiry report, proposals for a new Special Health Authority and managing risk around the expansion of virtual wards.
Medical Malpractice Forward View 2022
In this year’s forward view, we consider issues ranging from fixed recoverable costs in clinical negligence claims, claims resulting from COVID-19 treatment, major inquiries, clinical trials and healthcare technology.
There is likely to be an increase in the number of clinical trials
This year is likely to see a resurgence of non-Covid trials which have been postponed or paused in the last two years, and new trials for Covid treatments and vaccines (e.g. those based on conventional vaccine technology).
The latest on the Covid-19 Public Inquiry
Read the latest developments regarding the impending Public Inquiry, including what this means for you.
Procedures and policies, including national policy decisions, will be central to defending Covid-related claims
Delays to non-Covid treatment is the leading type of claim against NHS Trusts to date, followed by Hospital-Acquired Covid (HAC) and failure to treat Covid appropriately.
Inquests: failures of care during the pandemic may be scrutinised more closely, but ‘following the science’ will likely continue to be the dominant theme on causation
The vast majority of the inquest cases relate to acquisition of Covid-19 during hospital admission and staffing/resource issues. In a recent case a Coroner was critical of a decision not to escalate a patient’s care to ICU.
COVID-19: Workforce FAQs
The COVID-19 pandemic continues to pose significant workforce issues for healthcare organisations regarding the services they provide and the risks to staff. Here we share our FAQs in relation to these policies and communications with staff generally.